22NW, LP - LIANBIO ownership

LIANBIO's ticker is and the CUSIP is 53000N108. A total of 41 filers reported holding LIANBIO in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
22NW, LP ownership history of LIANBIO
ValueSharesWeighting
Q3 2023$3,295,400
+923.5%
2,211,678
+1466.1%
2.35%
+1068.2%
Q2 2023$321,988
+16.3%
141,2230.0%0.20%
+18.2%
Q1 2023$276,797
+19.5%
141,2230.0%0.17%
+36.0%
Q4 2022$231,606
-17.9%
141,2230.0%0.12%
-21.4%
Q3 2022$282,000
-7.5%
141,2230.0%0.16%
-1.9%
Q2 2022$305,000141,2230.16%
Other shareholders
LIANBIO shareholders Q4 2022
NameSharesValueWeighting ↓
Perceptive Advisors 112,639,920$693,862,0005.35%
Vida Ventures Advisors, LLC 2,282,084$14,058,0005.26%
VR Adviser, LLC 5,378,341$33,131,0004.53%
SCHF (GPE), LLC 937,500$5,775,0001.04%
RA Capital Management 7,655,015$47,155,0000.83%
TYBOURNE CAPITAL MANAGEMENT (HK) LTD 3,314,173$20,415,0000.61%
Logos Global Management LP 412,837$2,543,0000.26%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 1,782,747$10,982,0000.23%
SPHERA FUNDS MANAGEMENT LTD. 275,007$1,662,0000.18%
Affinity Asset Advisors, LLC 72,406$446,0000.16%
View complete list of LIANBIO shareholders